Assyro AI

FDA Orange Book · active-ingredient family

Benzoyl peroxide; erythromycin

Benzoyl peroxide; erythromycin is approved as 2 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:AKTIPAK · NDA 050769

2

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · gel

ProductApplicantApplicationTEApproved
AKTIPAKRLDBIOFRONTERANDA 050769Nov 27, 2000
BENZAMYCINRLDVALEANT INTLNDA 050557ABOct 26, 1984

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
ERYTHROMYCIN AND BENZOYL PEROXIDERISINGANDA 065385ABSep 18, 2015
ERYTHROMYCIN AND BENZOYL PEROXIDEENCUBEANDA 065112Mar 29, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Benzoyl peroxide; erythromycin — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.